GLP-1 Drugs Don’t Raise Postoperative Aspiration Pneumonia Risk, Study Finds
In 2023, the American Society of Anesthesiologists recommended discontinuing glucagon-like peptide-1 (GLP-1) receptor agonists before surgery over concerns about increased risk of aspiration pneumonia. But a study recently found no significant difference in postoperative aspiration pneumonia incidence between GLP-1 users and nonusers.
In 2023, the American Society of Anesthesiologists recommended discontinuing glucagon-like peptide-1 (GLP-1) receptor agonists before surgery over concerns about increased risk of aspiration pneumonia. But a study recently found no significant difference in postoperative aspiration pneumonia incidence between GLP-1 users and nonusers.
